Welcome to our dedicated page for Selectquote news (Ticker: SLQT), a resource for investors and traders seeking the latest updates and insights on Selectquote stock.
SelectQuote, Inc. (NYSE: SLQT) is described in its public communications as a leading distributor of Medicare insurance policies and the owner of a rapidly growing healthcare services platform. News about SLQT often centers on its SelectQuote Senior Medicare distribution business, its Healthcare Services segment anchored by the SelectRx pharmacy, and its SelectQuote Life insurance operations.
On this page, readers can follow company announcements about Medicare insurance distribution performance, healthcare services initiatives and capital structure developments. Recent releases have highlighted new credit facilities arranged with lenders, including a senior secured term loan and revolving credit facility used to refinance existing debt and support working capital. Other news has focused on multiyear agreements for SelectRx with pharmacy benefit manager partners aimed at providing more predictable reimbursement economics.
Company news also covers operational metrics and research from its Healthcare Services platform. SelectQuote has reported on SelectRx membership growth, prescriptions shipped per day, and research from its Healthcare Select division that examines chronic conditions, prescription use, social determinants of health and medication adherence among Medicare beneficiaries. Additional updates describe partnerships with social service platforms to connect low-income seniors with food, housing, transportation and other support programs.
Investors and observers can use this news feed to review earnings releases, segment results for Senior, Healthcare Services and Life, updates on Medicare Advantage policy volumes, and disclosures about new programs designed to improve medication adherence for polychronic Medicare beneficiaries. Regularly reviewing SLQT news provides context on how the company’s insurance distribution and healthcare services ecosystem is evolving over time.
SelectQuote reported a strong second quarter for fiscal 2023 with consolidated revenue of $319.2 million, up from $194.2 million the previous year. The company posted a net income of $22.5 million, compared to a net loss of $137.6 million in Q2 2022. Adjusted EBITDA reached $63.6 million, a significant recovery from $(164.0 million) in the prior year. The Senior segment contributed $223.8 million in revenue, while Healthcare Services had $55.5 million despite a negative EBITDA of $(9.3 million). SelectQuote has updated its fiscal year guidance, expecting revenue between $910 million and $960 million with a net loss range of $94 million to $78 million.
SelectQuote (NYSE: SLQT) will release its fiscal Q2 2023 financial results on February 7, 2023, prior to market open. CEO Tim Danker and interim CFO Ryan Clement will host a conference call at 8:30 am ET on the same day to discuss these results. The company specializes in unbiased insurance price comparisons, helping consumers secure suitable policies. SelectQuote serves diverse markets including Medicare and Value-Based Care through its four core business lines. This upcoming report is expected to provide insights into financial performance and future outlook.
SelectQuote, Inc. (NYSE: SLQT) announced preliminary financial results for Q2 FY2023, estimating revenue between $300 million to $320 million and net income of $11 million to $23 million. Full-year guidance now expects revenue of $890 million to $960 million, with a reduced net loss forecast of $98 million to $78 million. CEO Tim Danker attributed the positive results to improved performance in Medicare distribution and strategic enhancements in agent hiring and marketing efficiency.
SelectQuote, Inc. (NYSE: SLQT) plans a special meeting on March 2, 2023, to seek stockholder approval for a reverse stock split of its common stock with a par value of $0.01. Stockholders of record as of January 11, 2023, will be eligible to vote. The reverse stock split is designed to not affect stockholders' ownership percentages, though fractional shares may be converted to cash. Details regarding the split ratio will be communicated later. The Board has the discretion to delay or abandon the proposal if deemed unbeneficial.
SelectQuote, Inc. (SLQT) reported consolidated revenue of $162.5 million for Q1 FY 2023, up from $156.1 million in Q1 FY 2022. The company experienced a net loss of $42.5 million, improved from a loss of $48.2 million a year prior. Adjusted EBITDA was $(27.5) million, compared to $(47.9) million. Segment highlights included Senior Revenue of $77.5 million and Healthcare Services Revenue of $43.1 million. SelectQuote reaffirmed its FY 2023 guidance, expecting revenue between $850 million and $950 million.
SelectQuote, Inc. (NYSE: SLQT) has received a notice from the NYSE for failing to meet compliance with the stock price requirement, as its average closing price was below $1.00 over 30 consecutive trading days. The company plans to notify the NYSE of its intent to remedy this deficiency within a six-month cure period. During this time, SLQT's stock will continue trading on the NYSE, provided it meets other continued listing standards. The company aims to meet the $1.00 stock price requirement to regain compliance.
SelectQuote, Inc. (NYSE: SLQT) will release its fiscal Q1 2023 financial results on November 3, 2022, before market opening. The CEO Tim Danker and interim CFO Ryan Clement will host a conference call at 8:00 am ET to discuss the results. Investors can register for the call through a provided link, which also ensures a follow-up confirmation with entry details. SelectQuote has positioned itself as a leader in providing unbiased insurance comparisons, utilizing a skilled agent workforce and proprietary technology to serve consumers in various insurance sectors.
SelectQuote (NYSE: SLQT) has partnered with Symetra Life Insurance Company and Munich Re Life US to launch SwiftTerm Select, an innovative instant decision term life insurance product. This offering allows qualified consumers aged 18-60 to secure up to $2 million in same-day coverage without a medical exam, starting Q4 2022. The product emphasizes a premium, seamless experience through advanced technology and is aimed at transforming the life insurance market.
SelectQuote (NYSE: SLQT) has partnered with Rocket Lawyer to enhance its consumer offerings. Starting September 2022, SelectQuote customers will have access to Rocket Lawyer's legal services while shopping for insurance. This collaboration aims to provide an affordable solution for legal needs, allowing members to create customizable documents and connect with attorneys. SelectQuote's VP of Business Development, Phil Williamson, emphasized the importance of understanding consumer needs to develop integrated services. The partnership seeks to improve customer confidence in managing legal affairs alongside insurance.
SelectQuote (NYSE: SLQT) reported a fourth-quarter revenue of $139.4 million, down from $185.3 million a year prior. The company experienced a net loss of $104.7 million, compared to a net income of $0.8 million in Q4 2021. Adjusted EBITDA was $(60.8) million versus $18.1 million the previous year. For fiscal year 2023, revenue guidance is projected between $850 million and $950 million, with net losses expected to range from $113 million to $89 million.